| Genital Neoplasms, Male |
NCT01516762: Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases |
|
|
| No Longer Available | N/A | | US | Radium-223 dichloride (BAY88-8223) | Bayer | Prostatic Neoplasms | | | | |
|
NCT01777061: Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan |
|
|
| No Longer Available | N/A | | US | [11C]Acetate, carbon-11 acetate [[11C]acetate], sodium acetate [11C]Acetate injection | Wendell Yap, MD, University of Kansas Medical Center | Prostate Cancer | | | | |
NCT01834209: A Study of Abiraterone Acetate Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer |
|
|
| No Longer Available | N/A | | RoW | Abiraterone acetate, Prednisone or prednisolone | Janssen Research & Development, LLC | Prostate Neoplasms | | | | |
NCT02901392: Fundación IVO Registry for Patients Undergoing Sling or Artificial Urinary Sphincter After Prostate Cancer Treatment |
|
|
| Recruiting | N/A | 400 | Europe | AMS-800, ADVANCE/ADVANCEXP, VIRTUE, INVANCE | Fundación Instituto Valenciano de OncologÃa | Urinary Incontinence, Stress | 04/19 | 04/31 | | |
NCT02865330: Spanish Urological Association Registry of Patients on Active Surveillance |
|
|
| Recruiting | N/A | 946 | Europe | Registry | Fundación Instituto Valenciano de OncologÃa | Prostate Cancer | 06/19 | 07/34 | | |
NCT02186925: A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney. |
|
|
| Recruiting | N/A | 1000 | RoW | | Meir Medical Center | Kidney Cancer, Prostate Cancer, Bladder Cancer | 08/19 | 08/25 | | |
SUPER-PC-AS, NCT02971085: Seoul National University Prospectively Enrolled Registry for Prostate Cancer With Active Surveillance |
|
|
| Recruiting | N/A | 410 | RoW | Active surveillance | Seoul National University Hospital | Prostate Cancer | 01/22 | 01/27 | | |
| Recruiting | N/A | 354 | Europe | questionnaire administration, assessment of therapy complications, high-intensity focused ultrasound ablation, multiparametric magnetic resonance imaging, quality-of-life assessment, transperineal prostate biopsy, transrectal prostate biopsy | University College, London | Male Erectile Disorder, Prostate Cancer, Therapy-related Toxicity, Urinary Incontinence | 12/28 | 06/29 | | |
NCT02869594: Institut Paoli Calmettes Prostate Cancer Database |
|
|
| Recruiting | N/A | 10000 | Europe | Data collection | Institut Paoli-Calmettes | Prostatic Neoplasms | 01/30 | 12/30 | | |
NCT02588404: The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient |
|
|
| Not yet recruiting | N/A | 65 | Canada | LHRH therapy, Eligard, Lupron, Trelstar, and Zoladex | Sir Mortimer B. Davis - Jewish General Hospital | Prostate Cancer | 01/30 | | | |
